Gaurav Shah Net Worth & Insider Trades
Gaurav Shah - CEO, Rocket Pharmaceuticals, Inc
What is Gaurav Shah's Net Worth?
The current estimated net worth of Rocket Pharmaceuticals, Inc's CEO, Gaurav Shah, is estimated to be about $13.97M . Gaurav Shah owns about 715,980 units of Rocket Pharmaceuticals, Inc common stock. In the last 4 years at Rocket Pharmaceuticals, Inc, Gaurav Shah has sold an estimated value of $10.85M worth.
What is Gaurav Shah's Past Insider Trading?
Gaurav Shah's largest purchase order was 22,000 units , worth over $381.51K on February 8, 2022. Gaurav Shah's largest sale order was 74,900 units , worth over $1.29M on March 5, 2019. In total, Gaurav Shah has made about 11 transactions over 4 years of their time at Rocket Pharmaceuticals, Inc. Gaurav Shah usually trades in February, with the busiest year in 2020 and 2021.
Gaurav Shah
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What was Gaurav Shah's Salary in 2020?
The vast majority of their compensation came in the form of other earnings, plans or compensations of $6,859,135 , option awards of $5,821,735 , and other compensation of $11,400 .
What is Gaurav Shah's' Mailing Address?
- Mailing address is 430 East 29th Street Suite 1040 New York NY 10016 NY
Rocket Pharmaceuticals, Inc Executive Compensation
Name |
Year
|
Other Earnings Plans or Compensations
|
Other Earnings Plans or Compensations
|
Option Awards
|
Other Compensation
|
Other Earnings Plans or Compensations
|
|---|---|---|---|---|---|---|
| Gaurav D. Shah, M.D. | 2020 | $6,859,135 | $6,859,135 | $5,821,735 | $11,400 | $6,859,135 |
| Gaurav D. Shah, M.D. | 2019 | $3,883,646 | $3,883,646 | $3,043,306 | $11,200 | $3,883,646 |
| Gaurav D. Shah, M.D. | 2018 | $6,375,752 | $6,375,752 | $5,651,220 | $9,857 | $6,375,752 |
| Kinnari Patel, Pharm.D., MBA | 2020 | $4,080,621 | $4,080,621 | $3,254,721 | $11,400 | $4,080,621 |
| Kinnari Patel, Pharm.D., MBA | 2019 | $2,776,209 | $2,776,209 | $2,092,294 | $11,200 | $2,776,209 |
| Kinnari Patel, Pharm.D., MBA | 2018 | $2,991,073 | $2,991,073 | $2,423,050 | $11,066 | $2,991,073 |
| Jonathan Schwartz, M.D., | 2020 | $1,870,733 | $1,870,733 | $1,251,033 | $11,400 | $1,870,733 |
| Jonathan Schwartz, M.D., | 2019 | $1,475,675 | $1,475,675 | $937,261 | $8,165 | $1,475,675 |
| Jonathan Schwartz, M.D., | 2018 | $1,356,675 | $1,356,675 | $830,761 | $8,854 | $1,356,675 |
| Kamran Alam | 2020 | $634,250 | $634,250 | $427,670 | $9,350 | $634,250 |
| Kamran Alam | 2019 | $2,051,457 | $2,051,457 | $1,916,912 | - | $2,051,457 |
| John Militello, Controller and Treasurer Principal Controller and Treasurer Principal | 2020 | $1,003,053 | $1,003,053 | $617,270 | $11,400 | $1,003,053 |
| No matching records found | ||||||
Source: https://www.sec.gov/Archives/edgar/data/1281895/000114036121015285/nc10023585x1_def14a.htm
What are Rocket Pharmaceuticals, Inc's Past Insider Trades?
Rocket Pharmaceuticals, Inc's most recent insider trade came on October 11, 2022 by Rtw Investments Lp and Roderick Wong who bought 1,355,932 units worth $20M . In the last 4 years, insiders at Rocket Pharmaceuticals, Inc have sold an estimated value of $44.68M and bought an estimated value of $92.53M worth of shares. Insider trading is most common in June, with the busiest year in 2022. The most active traders at the company are Roderick Wong, Director, Naveen Yalamanchi, and Kinnari Patel, See Remarks .
ROCKET PHARMACEUTICALS, INC. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||